ODDB.org: Open Drug Database

Swissmedic Registration	67351	Date of registration	13.02.2020
Company name	GlaxoSmithKline AG	Revision date
		Valid until
Indication		Date of market entry
Index Therapeuticus (BSV)	03.04.50.	Revocation Date
Index Therapeuticus (Swissmedic)	03.04.50.	Information for professionals	IP

Seq.-No.	Product	Description	Galenic form	ATC-classification
01	Nucala 100 mg/mL	Injektionslösung in der Fertigspritze	Injektionslösung in der Fertigspritze (Mepolizumabum 100mg / 1ml)	R03DX09	CI

2025	©ywesee GmbH